Edwards Lifesciences Corporation Common Stock vs Flowserve Corporation Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Flowserve Corporation Common Stock trades at $70.6 (market cap $8.85B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 5.5× Flowserve Corporation Common Stock's market cap, and Flowserve Corporation Common Stock pays a 1.26% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | FLS | |
|---|---|---|
Market Cap | $48.56B | $8.85B |
Volume | 6,520,488 | 1,955,324 |
Sector | Health | Industrials |
52-Week High | $95.18 | $92.04 |
52-Week Low | $72.65 | $49.09 |
Enterprise Value | $45.01B | $10.44B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 1.26% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →